assessment on all patients. Annual follow-up was carried out with the same assessment over a five-year period.
Sociodemographic data
The data recorded included age, sex, native language, marital status, living arrangement and educational level.
Telomere length measurements
Telomere length were determined as a function of fluorescence intensity, using an FITC-labeled peptide nucleic acid (PNA) probe (FITC-coupled) supplied with the telomere PNA /FITC for flow cytometry kit by DAKO (http://www. dakousa.com/prod_downloadpackageinsert.pdf?objectid=11479 1002).
In situ hybridization: Lymphocytes were prepared for hybridization in the presence of hybridization solution without probe or in hybridization solution containing fluoresceinconjugated PNA telomere probe, as described in Hultdin et al. (17) . Flow cytometry: Labelled cells were analyzed by flow cytometry. Homogeneous lymphocyte subpopulations were identified. DNA was labelled with DAPI to identify cell populations with similar DNA content, with gating on the G1 population. FITC-labelled cells were counted in the gated population. As an internal control, telomere length was measured in a standard cell line (HL60), which allowed normalizing the flow cytometric measurements with respect to day to day variations. Image analysis was performed with the same flow cytometer (FACS, Fluorescence Activated Cell Sorting; Partec PAS Flow Cytometer Galaxy, USA) in each case. Mean telomere fluorescence intensity was calculated as the difference between the fluorescence signal obtained with samples hybridized with the Telomere PNA Probe/FITC and the fluorescence signal obtained with a sample of the same cells incubated with the hybridization solution without probe. Results are expressed as telomere length index, which is the fluorescent signal obtained in the patient cells divided by the fluorescent signal of the control HL-60 cells. Thus, a telomere length index of 1 indicates a telomere length in the patient sample identical to the one observed in HL-60 cells. The intraassay coefficient of variance of this measurement was less than 2%.
Nutritional assessment
Body mass index (BMI kg/m 2 ) was determined and the short version of the Mini Nutritional Assessment (MNA) (score ranging from 0 to 14, ≥ 12 being normal) administered on admission, by the same nurse in each case (18) . The reference period for the MNA was two weeks before admission. Albumin blood level (g/l) was measured by bromocresol purple dyebinding method.
Functionality
Base and Instrumental Activities of Daily Living (ADL, IADL) (19, 20) scores were determined as a function of patient status two weeks before admission, based on the patient's medical history or information supplied by an informal or formal carer.
Assessment of Comorbidity
From our previous work on this cohort (21) the best prognostic predictor of 5-year mortality was the Geriatric Index of Comorbidity (GIC) (22) class 4 multiplying the risk of death by 4, thus we used this comorbidity score in this study. The same geriatrician calculated this score for each patient, via an extensive review of the patient's medical records and administrative data for diagnoses established at or before enrolment in this study and by standardized interviews with patients and surrogates. The GIC classifies patients into four classes of increasing somatic comorbidity.
Cognitive diagnosis
The same neuropsychologist assessed all subjects for clinical dementia, The MMSE (23) and the Short Cognitive Evaluation Battery were used (24, 25) . Based on screening results, the neuropsychologist then carried out a comprehensive standardized neuropsychological assessment to determine the etiology and severity of clinical dementia, as previously described (14, 15) . The formal clinical criteria used for diagnosis were those of the DSM IV-TR (26), NINCDS-ADRDA (27) and NINDS-AIREN (28) . Cerebral imaging was also carried out.
Outcome
The outcome of interest was death by December 31, 2009 , that means an average 60 months (five years) of follow-up. This information was obtained through yearly phone calls to the patient, his family and/or his general practitioner. Mortality data was also confirmed through access to the population registrar of the State of Geneva.
Statistical methods
We checked the normality of the data distribution with skewness and kurtosis tests, and carried out standard transformations to normalise non-Gaussian variables. Data for continuous variables are presented as means ± 1 standard deviation (SD).
First, we measured the univariate relationship between each independent variable and 5-year mortality. We used Cox proportional hazards models to take into account the time to the event. The independent variables assessed as possible predictors included age, sex, telomere length, nutritional and functional status before admission (MNA, ADL and IADL scores), albumin level and BMI at admission, comorbidity score and cognitive diagnosis (normal or demented). We also used Kaplan-Meier survival curves to examine the performance of the independent variables over time. We then entered all independent variables and 5-year mortality as dependent variable in multivariate Cox regression. Hazards ratios (HR) along with their 95% confidence intervals (CI) were calculated. Continuous variables were either included as such or dichotomized, using the lower cut-off value (MNA, ADL and IADL). As it was not possible to normalize telomere length and BMI scores, they were categorized into tertiles for telomere length (lower tertile ≤ 0.49 (95% CI 0.44-0.52), reference tertile: 0.49-0.77 and upper tertile > 0.77 (95% CI 0.72-0.82)) and quartiles for BMI (< 20 kg/m2, 20-25 kg/m 2 = reference, 25-30 kg/m 2 and > 30 kg/m 2 ). The proportional-hazards assumption was successfully tested for telomere length based on Schoenfeld residuals. Pseudo R-squared (R 2 ) which provides information on the amount of variance explained by the model were computed using the Stata "str2ph" command based on the Royston's modification of O'Quigley, Xu & Stare's modification of Nagelkerke's R 2 statistic for proportionalhazards models with censored survival data (29) . The comorbidity score applied, the GIC is predefined into four classes. As there were only 2% of the patients classified as class 1 by the GIC, they were combined with class 2 for the analysis and considered as the standard. Statistical analyses were performed with Stata software version 11, TX, US.
Results 556 patients were randomized, 523 were successfully enrolled and 496 survived to hospital discharge (27 died during the hospitalization), 444 patients had full data and were included in this study (mean age 85.3 ± 6.7; 74 % women). Of the 444 patients, 263 died during the five years after discharge (59.2%). The distribution of patients according to sex, telomere length, BMI, MNA, albumin level, ADL, IADL, comorbidity score and cognitive function on baseline and those who died after 5 years of follow-up are described in Table 1 .
Univariate and multiple Cox proportional hazards modeling (Table 2)
In univariate analysis, 5 year-mortality was significantly associated with age, each supplementary year added 7% to the risk of death (R 2 = 9.5%, HR = 1.07, 95% CI = 1.05 -1.09); being a men increased the risk by 1.5 fold (R 2 = 1.9%, HR = 1.52, 95% CI = 1.17 -1.98). The telomere length, the cognitive status and the MNA score were not predictor of the outcome.
The best prognostic predictor was the GIC class 4 (R 2 = 8.8%, HR = 1.07HR = 3.85, 95% CI = 2.29 -6.47). After 5 years, approximately 80% of the high score patients were already deceased, compared with less than 40% in the lowest scores.
The When all variables were included in the full model while adjusting for age and sex (R2 = 21.4%), the GIC class 4 (HR = 2.45, 95% CI = 1.40 -4.28) remained the best predictor independently associated with 5-year mortality followed by the IADL (HR = 0.91, 95% CI = 0.84 -0.98), the albumin level (HR = 0.97, 95% CI = 0.95 -1.00); the BMI > 30 (HR = 0.60, 95% CI = 0.37 -0.98); age (HR = 1.06, 95% CI = 1.03 -1.08) and sex (HR = 1.69, 95% CI = 1.27 -2.24).
Discussion
The purpose of this paper was to evaluate the weight of a biological predictor (telomere length) alone and compared to other well known health predictors of 5-year mortality after discharge of very elderly patients hospitalized in acute care. It was hypothesized that poor health variables exceed biological factors like telomere length measure. This study confirmed the importance of disability, comorbidity and malnutrition as specific independent predictors in a very old population. One of the main strengths of this study was the standardized comprehensive assessment: the same geriatrician scored the presence and the extent of comorbidity for all patients, the same neuropsychologist carried out a systematic, complete neuropsychological assessment of all the included patients, increasing the accuracy of cognitive diagnosis, the same nurse scored functional and nutritional tools and finally the same biologist assessed the leukocyte telomere length.
Several studies have examined telomere length as determinant of mortality in the elderly. There is considerable inconsistency in the current literature. Some reports have shown associations of shorter telomere length with lower survival: Cawthon and colleagues (9) , in their study of individuals 60 years old or older, demonstrated that the overall mortality rate of persons with short telomeres was nearly double that of individuals with long telomeres; Bakaysa et al. (30) reported that twins with shorter telomere length have three times the risk of death compared with their co-twins with longer telomere length. In contrast other studies showed no association between leukocyte telomere length and survival in older individuals' aged more than 85 years (11, 12) . More recently, Terry et al. had examined telomere length in centenarians in good health versus poor health. Healthy centenarians had significantly longer telomeres than did unhealthy centenarians (p = 0.0475) (31) . They have demonstrated that investigations of the association between telomere length and exceptional longevity must take into account the health status of the individuals and have raised the possibility that perhaps it is not exceptional longevity but one's function and health that may be associated with telomere length. Our results confirmed this hypothesis.
In our population of very old patients, a 5-year mortality rate of almost 60% was found after discharge. This rate was similar to that reported in previous studies. Age per se is a well-known negative prognostic risk factor for death and explained almost 10% of the variance of the outcome in this study. Nonetheless, higher comorbidity, poor functional and nutritional status were factors that negatively affected survival. Similarly to our results, previous studies have shown that worse functional status prior to and at hospital admission is associated with a higher short and long-term mortality (32, 33) as well as higher comorbidity scores and worse nutritional status (34, 35) .
Curiously, in this study, the univariate model shows only a trend regarding dementia as a predictor of 5-year mortality. This trend had completely disappeared when all the variables were added in the full model. On the contrary, many studies have examined survival in relation to dementia and the majority has reported that dementia increases the risk of death compared to no dementia (36, 37) . Recently, a Danish population-based cohort study (14 years of follow-up) involving 3,065 nondemented and 234 demented at baseline , showed that the hazard ratio of death (95% confidence interval) increased from 1.82 (1.55-2.14) for the very mildly demented to 9.52 (6.60-13.74) for the severely demented subjects (38) . The majority of these studies are population based and have examined survival from the time of diagnosis of dementia, whereas our study, which was not designed for this purpose, was based on a selected group in a clinical setting and 42% of the cohort had dementia diagnosis at baseline. Our study has some limitations. First, since it focused on hospitalized elderly patients, it is likely that it is difficult to generalize its conclusions to institutionalized and community dwelling subjects. Second, only one center was involved so the results have to be confirmed in others centers. Third the enrolled patients were very old, acutely ill, and had a high burden of comorbidities.
In conclusion, in this cohort of oldest old, neither leukocyte telomere length nor the presence of dementia are predictors of 5-year survival whereas the weight of multiple comorbidity conditions, nutritional and functional impairment are. Hospital discharge planning and prognosis can help physicians and family members plan for the care of patients who may be at increased risk of adverse outcomes in the coming years, especially regarding discussions of goals of care, treatment preferences, advance planning, and clinical therapeutic options. Hospitalization therefore may present a key trigger point to identify persons at greatest risk for mortality in the years following discharge.
